recombinant human lactoferrin

DRUG2 trials

Sponsors

Agennix, Johns Hopkins University

Conditions

Carcinoma, Renal CellClostridium Difficile

Phase 2

Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma

CompletedNCT00095186

AgennixCarcinoma, Renal Cell

Start: 2004-09-30End: 2007-03-31Target: 40Updated: 2008-04-10

Unknown Phase

Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.

Johns Hopkins UniversityClostridium Difficile

Start: 2005-10-31End: 2007-10-31Target: 30Updated: 2006-09-15